Oscar Health, Inc. (NYSE:OSCR) Receives Average Rating of “Hold” from Analysts

Oscar Health, Inc. (NYSE:OSCR) has earned a consensus rating of “Hold” from the nine brokerages that are currently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $21.56.

A number of brokerages have issued reports on OSCR. Jefferies Financial Group started coverage on Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price target for the company. UBS Group initiated coverage on Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 target price on the stock. Finally, Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price target for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th.

Oscar Health Price Performance

NYSE OSCR opened at $14.12 on Friday. The company has a 50-day moving average price of $15.10 and a two-hundred day moving average price of $16.89. The stock has a market cap of $3.49 billion, a price-to-earnings ratio of -235.29 and a beta of 1.70. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health has a 52 week low of $9.70 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. During the same quarter in the prior year, the business earned ($0.29) earnings per share. The firm’s revenue was up 68.3% compared to the same quarter last year. Analysts forecast that Oscar Health will post -0.01 EPS for the current year.

Insiders Place Their Bets

In related news, COO Steven Wolin sold 19,580 shares of Oscar Health stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $354,006.40. Following the completion of the sale, the chief operating officer now owns 102,598 shares of the company’s stock, valued at approximately $1,854,971.84. This trade represents a 16.03 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Mario Schlosser sold 6,516 shares of the company’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $117,809.28. Following the completion of the transaction, the insider now directly owns 81,962 shares in the company, valued at approximately $1,481,872.96. The trade was a 7.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders acquired 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. Corporate insiders own 25.11% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

Several large investors have recently made changes to their positions in OSCR. Westfield Capital Management Co. LP acquired a new stake in Oscar Health in the third quarter valued at approximately $27,452,000. JPMorgan Chase & Co. raised its holdings in shares of Oscar Health by 68.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock valued at $48,977,000 after purchasing an additional 938,742 shares in the last quarter. Renaissance Technologies LLC lifted its stake in shares of Oscar Health by 31.7% in the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock valued at $61,478,000 after purchasing an additional 934,600 shares during the last quarter. Point72 Asset Management L.P. bought a new stake in Oscar Health in the second quarter worth $14,716,000. Finally, Soros Fund Management LLC bought a new stake in Oscar Health in the third quarter worth $12,726,000. Institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.